Tag
#FDA
DiseasesKeytruda (pembrolizumab) is approved for cancer solid tumors
Keytruda Keytruda (pembrolizumab) is indicated for the treatment of adult and pediatric patients with unresectable or metastatic solid tumors that have been identified as having a biomarker referred to as microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Indications Metastatic Melanoma. Unresectable Melanoma. Refractory, metastatic Non-small cell lung cancer. Keytruda mechanism of Action Keytruda works…
May 23, 2017
- News & Updates
Radicava (edaravone) approved for ALS by FDA
What is Radicava? Do you remember the Ice Bucket Challenge, the challenge that carried out by most famous people and passed to others as an awareness campaign for amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. Amyotrophic lateral sclerosis (ALS) ALS is a rare disease that attacks and kills the nerve cells…
May 5, 2017
Drug factsDrug Approval Process – explained by images
A drug is any product that is intended for use in the diagnosis, cure mitigation, treatment , or prevention of disease; and that is intended to affect the structure or any function of the body. Before a drug can be used, it must pass the FDA’s approval process. This process involves first testing the drug…
Mar 28, 2017
DiseasesSiliq (brodalumab) approved as a new psoriasis drug by FDA
Psoriasis is a skin condition that causes patches of skin redness and flaking. Psoriasis is an autoimmune disorder that occurs more commonly in patients with a family history of the disease, and most often begins in people between the ages of 15 and 35. The most common form of psoriasis is plaque psoriasis, in…
Feb 15, 2017
Drug factsFDA warns severe joint pain may be caused by Gliptins – DPP-4 inhibitors
DPP-4 inhibitors used to treat type 2 diabetes, this class includes different brands in single molecule or combined with other molecules like metformin. DPP-4 inhibitors brands: Brand name Active ingredient(s) Januvia sitagliptin Janumet sitagliptin and metformin Janumet XR sitagliptin and metformin extended release Onglyza saxagliptin Kombiglyze XR saxagliptin and metformin extended release Tradjenta linagliptin Glyxambi…
Aug 28, 2015